Related Experiment Video

Updated: Aug 16, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Homocysteine and brain atrophy

Perminder S Sachdev1

  • 1School of Psychiatry, University of New South Wales, Sydney NSW 2052, Australia. p.sachdev@unsw.edu.au

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|August 17, 2005
PubMed

Insights

High homocysteine (Hcy) is linked to brain atrophy and neurodegenerative diseases like Alzheimer's. Further intervention studies are needed to confirm its role and explore potential treatments for these conditions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Vascular Biology

Background:

  • Homocysteine (Hcy) is associated with vascular disease and brain atrophy.
  • Mechanisms include oxidative stress, DNA damage, apoptosis, excitotoxicity, and vascular wall damage.
  • Hcy is prothrombotic and proatherogenic.

Purpose of the Study:

  • To review the role of homocysteine in neurodegeneration and brain atrophy.
  • To explore the association of Hcy with cognitive impairment, Alzheimer's Disease (AD), and Parkinson Disease (PD).
  • To highlight the potential of Hcy as a target for intervention in degenerative brain disorders.

Main Methods:

  • Literature review of epidemiological and longitudinal data.
  • Analysis of proposed mechanisms linking Hcy to neurodegeneration.
  • Discussion of Hcy's role in alcohol-related brain atrophy.

Main Results:

  • Hcy is implicated in brain atrophy, particularly in older individuals, and potentially white matter hyperintensities (WMH).
  • Epidemiological data support Hcy as a risk factor for cognitive impairment and AD, possibly via cerebrovascular and neurotoxic pathways.
  • The role of Hcy in PD is less established, but it may mediate alcohol-related brain atrophy.

Conclusions:

  • High homocysteine is a significant risk factor for vascular disease and neurodegeneration.
  • Its prevalence and treatability make it a promising target for future intervention studies.
  • Further intervention studies are crucial to confirm Hcy's etiological role in degenerative brain disorders.

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...